East meets West: An herbal tea finds a receptor

Journal of Clinical Investigation

Volumn 113, Issue 1, 2004, Pages 23-25

  Lazar, Mitchell A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BILIRUBIN; CELL NUCLEUS RECEPTOR; CHINESE DRUG; CONSTITUTIVE ANDROSTANE RECEPTOR; ESTROGEN RECEPTOR; HERBACEOUS AGENT; HISTONE DEACETYLASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESVERATROL; UNCLASSIFIED DRUG; YIN ZHI HUANG; DRUG RECEPTOR;

BILIRUBIN BLOOD LEVEL; CHINESE MEDICINE; CLEARANCE; DRUG EFFECT; DRUG EFFICACY; DRUG TARGETING; DRUG UTILIZATION; HERBAL MEDICINE; HUMAN; NEUROTOXICITY; NEWBORN JAUNDICE; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; PROTEIN INDUCTION; REVIEW; SIGNAL TRANSDUCTION; TEA; BEVERAGE; JAUNDICE; NOTE; PHYSIOLOGY; PHYTOTHERAPY;

BEVERAGES; HUMANS; JAUNDICE; MEDICINE, CHINESE TRADITIONAL; MEDICINE, HERBAL; PHYTOTHERAPY; RECEPTORS, DRUG;

EID: 1542676326     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200420661     Document Type: Review

References (27)

1. Kinsella, K., and Gist, Y.J. 1998. Gender and Aging: Mortality and Health. U.S. Department of Commerce, U.S. Bureau of the Census. Washington, D.C. 1B/98-2.
2. Carey, J. 2003. Herbal remedies: a $4 billion enigma. Business Week online, 28 April. http://www.businessweek.com/magazine/content/03_17/b3830095_mz025.htm.
3. Huang, W., Zhang, J., and Moore, D.D. 2004. A traditional herbal medicine enhances bilirubin clearance by activating the nuclear receptor CAR. J. Clin. Invest. 113:137-143. doi:10.1172/JC1200418385.
4. Huang, W., et al. 2003: Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc. Natl. Acad. Sci. U. S. A. 100:4156-4161.
5. Xie, W., et al. 2003. Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc. Natl. Acad. Sci. U. S. A. 100:4150-4155.
6. Eisenberg, D.M. 1997. Advising patients who seek alternative medical therapies. Ann. Intern. Med. 127:61-69.
7. Chawla, A., Repa, J.J., Evans, R.M., and Mangelsdorf, D.J. 2001. Nuclear receptors and lipid physiology: opening the X files. Science. 294:1866-1870.
8. Lazar, M.A. 2003. Mechanism of action of hormones that act on nuclear receptors. In Williams textbook of endocrinology. P.R. Larsen, H.M. Kronenberg, S. Melmed, and K.S. Polonsky, editors. W.B. Saunders Co. Philadelphia, Pennsylvania, USA. 35-44.
9. Willson, T.M., and Moore, J.T. 2002. Genomics versus orphan nuclear receptors: a half-time report. Mol. Endocrinol. 16:1135-1144.
10. Klinge, C.M., et al. 2003. Estrogenic activity in white and red wine extracts. J. Agric. Food Chem. 51:1850-1857.
11. Howitz, K.T., et al. 2003. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 425:191-196.
12. Etgen, G.J., et al. 2002. A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models. Diabetes. 51:1083-1087.
13. Schwartz, T.B. 1999. Henry Harrower and the turbulent beginnings of endocrinology. Ann. Intern. Med 131:702-706.
14. Bhavnani, B.R. 2003. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's. J. Steroid Biochem. Mol. Biol. 85:473-482.
15. Stevenson, D.K., Wong, R.J., Hintz, S.R., and Vreman, H.J. 2002. The jaundiced newborn. Understanding and managing transitional hyperbilirubinemia. Minerva Pediatr. 54:373-382.
16. Dennery, P.A., Seidman, D.S., and Stevenson, D.K. 2001. Neonatal hyperbilirubinemia. N. Engl. J. Med. 344:581-590.
17. Usui, T., et al. 2002. The phytochemical lindleyin, isolated from Rhei rhizoma, mediates hormonal effects through estrogen receptors. J. Endocrinol. 175:289-296.
18. Chan, R.Y., Chen, W.F., Dong, A., Guo, D., and Wong, M.S. 2002. Estrogen like activity of ginsenoside Rg1 derived from Panax notoginseng. J. Clin. Endocrinol. Metab. 87:3691-3695.
19. Hsieh, T.C., Lu, X., Chea, J, and Wu, J.M. 2002. Prevention and management of prostate cancer using PC-SPES: a scientific perspective. J. Nutr. 132(Suppl.):3513S-3517S
20. Zava, D.T., Dollbaum, C.M., and Blen, M. 1998. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc. Soc. Exp. Biol. Med. 217:369-378.
21. Zhang, L.N., et al. 2000 Determination of vitamin D2 included with beta-cyclodextrin complex in "longmu zhuanggu chongji" by HPLC. Se Pu. 18:52-54.
22. Huang, M.E., et al. 1988. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood. 72:567-572.
23. Urizar, N.L., et al. 2002. A natural product that lowers cholesterol as an antagonist ligand for FXR. Science. 296:1703-1706.
24. Jardat, M.S., Noonan, D.J., Wu, B., Avery, M.A., and Feller, D.R. 2002. Pseudolaric acid analogs as a new class of peroxisome proliferator-activated receptor agonists. Planta Med. 68:667-671.
25. Moore, L.B., et al. 2000. St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl. Acad. Sci. U. S. A. 97:7500-7502.
26. Beck, V., Unterrieder, E., Krenn, L., Kubelka, W., and Jungbauer, A. 2003. Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy. J. Steroid Biochem. Mol. Biol. 84:259-268.
27. Takahashi, N., et al. 2002. Dual action of isoprenols from herbal medicines on both PPARgamma and PPARalpha in 3T3-L1 adipocytes and HepG2 hepatocytes. FEBS Lett. 514:315-322.